Nivolumab in Relapsed or Refractory Follicular Lymphoma

• Research type

  Research Study

• Full title

  A Single-Arm, Open-Label Phase 2 Study of Nivolumab (BMS-936558) in Subjects with Relapsed or Refractory Follicular Lymphoma (FL)

• IRAS ID

  145501

• Contact name

  Peter Johnson

• Contact email

  johnsonp@soton.ac.uk

• Sponsor organisation

  Bristol-Myers Squibb International Corporation

• Eudract number

  2013-003645-42

• ISRCTN Number

  n/a

• Clinicaltrials.gov Identifier

  n/a

• REC name

  South Central - Berkshire Research Ethics Committee

• REC reference

  14/SC/0028

• Date of REC Opinion

  3 Feb 2014

• REC opinion

  Favourable Opinion